• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫疗法:用更少的变应原进行治疗?

Immunotherapy: Treating with Fewer Allergens?

作者信息

Damask Cecelia

机构信息

Private Practice, Florida Hospital Altamonte Springs, 795 Primera Boulevard Suite 1031, Lake Mary, FL 32746, USA; University of Central Florida College of Medicine, 6850 Lake Nona Boulevard, Orlando, FL 32827, USA.

出版信息

Otolaryngol Clin North Am. 2017 Dec;50(6):1153-1165. doi: 10.1016/j.otc.2017.08.012. Epub 2017 Sep 28.

DOI:10.1016/j.otc.2017.08.012
PMID:28964528
Abstract

Polysensitization, sensitization to more than one allergen, is a common feature of patients with allergic rhinitis, and may be a risk factor for subsequent development of allergic diseases, especially allergic asthma. However, a polysensitized patient does not necessarily have polyallergy, a documented, causal relationship between exposure to 2 or more specific, sensitizing allergens and the subsequent occurrence of relevant clinical symptoms of allergy. Allergen immunotherapy treatment strategy for the polysensitized patient in Europe is to treat the single or 2 most clinically relevant allergen(s), whereas patients in the United States are usually treated for all potential clinically relevant allergens.

摘要

多致敏现象,即对一种以上过敏原致敏,是过敏性鼻炎患者的常见特征,可能是后续发生过敏性疾病尤其是过敏性哮喘的危险因素。然而,多致敏患者不一定患有多重过敏症,多重过敏症指接触两种或更多特定致敏过敏原与随后出现相关过敏临床症状之间存在记录在案的因果关系。在欧洲,针对多致敏患者的变应原免疫治疗策略是治疗单一或两种临床上最相关的变应原,而在美国,患者通常会针对所有潜在的临床上相关的变应原进行治疗。

相似文献

1
Immunotherapy: Treating with Fewer Allergens?免疫疗法:用更少的变应原进行治疗?
Otolaryngol Clin North Am. 2017 Dec;50(6):1153-1165. doi: 10.1016/j.otc.2017.08.012. Epub 2017 Sep 28.
2
Allergen immunotherapy (AIT) for the multiple-pollen sensitive patient.针对多重花粉敏感患者的变应原免疫疗法(AIT)。
Expert Rev Clin Pharmacol. 2016 Nov;9(11):1443-1451. doi: 10.1080/17512433.2016.1237874. Epub 2016 Oct 6.
3
Efficacy and Safety of Subcutaneous and Sublingual Immunotherapy for Allergic Rhinoconjunctivitis and Asthma.皮下和舌下免疫疗法治疗变应性鼻结膜炎和哮喘的疗效与安全性
Otolaryngol Clin North Am. 2017 Dec;50(6):1111-1119. doi: 10.1016/j.otc.2017.08.011. Epub 2017 Sep 28.
4
Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: looking at the published evidence.多过敏原和单过敏原免疫治疗策略在多敏患者中的应用:基于现有研究证据的探讨。
J Allergy Clin Immunol. 2012 Apr;129(4):929-34. doi: 10.1016/j.jaci.2011.11.019. Epub 2012 Jan 11.
5
Management of polysensitized patient: from molecular diagnostics to biomolecular immunotherapy.多敏化患者的管理:从分子诊断到生物分子免疫治疗
Expert Rev Clin Immunol. 2015;11(9):973-6. doi: 10.1586/1744666X.2015.1062365. Epub 2015 Jul 4.
6
Multiallergen-specific immunotherapy in polysensitized patients: where are we?多过敏原特异性免疫治疗在多敏患者中的应用:我们现在处于什么阶段?
Immunotherapy. 2013 Feb;5(2):183-90. doi: 10.2217/imt.12.161.
7
Immunotherapy in allergic rhinitis and lower airway outcomes.变应性鼻炎和下呼吸道结局的免疫治疗。
Allergy. 2017 Jan;72(1):35-42. doi: 10.1111/all.12989. Epub 2016 Aug 15.
8
A molecular diagnostic algorithm to guide pollen immunotherapy in southern Europe: towards component-resolved management of allergic diseases.一种用于指导南欧花粉免疫治疗的分子诊断算法:实现过敏性疾病的成分分辨管理。
Int Arch Allergy Immunol. 2013;162(2):163-72. doi: 10.1159/000353113. Epub 2013 Jul 31.
9
Molecular Aspects of Allergen-Specific Immunotherapy in Patients with Seasonal Allergic Rhinitis.季节性变应性鼻炎患者过敏原特异性免疫治疗的分子方面。
Cells. 2023 Jan 20;12(3):383. doi: 10.3390/cells12030383.
10
Clinical efficacy of immunotherapy in allergic rhinitis.免疫疗法在变应性鼻炎中的临床疗效。
Am J Rhinol Allergy. 2016 Sep 1;30(5):4-7. doi: 10.2500/ajra.2016.30.4368.